Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Effects of Rosiglitazone on Post Prandial Glycaemia in Type 2 Diabetic Patients.
rosiglitazone
49653/140
Diabetes Mellitus, Type 2
Phase 3
 
An analysis-ready dataset and a reporting and analysis plan are not available for this study. An annotated case report form is not available for this study. A blank case report form will be provided. A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
February 2015

Powered by ideaPoint, Inc.